{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:34Z","timestamp":1760189614430},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.transproceed.2018.02.118","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T11:33:09Z","timestamp":1521372789000},"page":"1834-1837","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tylicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Debska-Slizien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.02.118_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2018.02.118_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ahj.2004.04.037","article-title":"Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"148","author":"Kjeldsen","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.transproceed.2018.02.118_bib3","first-page":"900","article-title":"Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions","volume":"25","author":"Tylicki","year":"2012","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.118_bib4","first-page":"155","article-title":"Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment","volume":"30","author":"Ponticelli","year":"2017","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.118_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.02.118_bib6","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.02.118_bib7","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.transproceed.2018.02.118_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.118_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/TP.0000000000000139","article-title":"Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers","volume":"97","author":"Opelz","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.118_bib10","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.118_bib11","first-page":"291","article-title":"The effect of renin-angiotensin system inhibitors on kidney allograft survival: a systematic review and meta-analysis","volume":"8","author":"Cheungpasitporn","year":"2016","journal-title":"N\u00a0Am J Med Sci"},{"key":"10.1016\/j.transproceed.2018.02.118_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2018.02.118_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0b013e3182827a43","article-title":"Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial","volume":"95","author":"Paoletti","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.118_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.transproceed.2018.02.118_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.02.118_bib16","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.transproceed.2009.07.078","article-title":"Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications","volume":"41","author":"Malyszko","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.02.118_bib17","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/j.transproceed.2010.09.025","article-title":"Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory","volume":"42","author":"Przybylowski","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T03:18:08Z","timestamp":1532661488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518303051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0041134518303051"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.118","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}